$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
BD to Announce Financial Results for its Third Quarter of Fiscal 2023
04:15pm, Thursday, 06'th Jul 2023
FRANKLIN LAKES, N.J. , July 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results f
The 7 Most Undervalued Blue-Chip Stocks to Buy Now: June 2023
08:40pm, Tuesday, 27'th Jun 2023
Looking for undervalued blue-chip stocks to buy? This is a great time to be doing so.
Dividend Champion, Contender, And Challenger Highlights: Week Of June 25
10:28am, Sunday, 25'th Jun 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Becton, Dickinson and Company: Still Not Very Healthy
07:06pm, Tuesday, 20'th Jun 2023
Becton, Dickinson and Company has seen another year of relative stagnation. Following the spinoff of the Diabetes Care unit, sales and earnings have taken a small setback. Valuations remain full at ar
BD's (BDX) Latest Product to Automate Clinical Flow Cytometry
12:17pm, Thursday, 15'th Jun 2023
The latest worldwide commercial availability of BD's (BDX) product is expected to lead to increased automation in clinical lab workflow.
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
11:33am, Tuesday, 13'th Jun 2023
Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.
Becton, Dickinson: Business Should Beat H2 2023 Expectations
04:50am, Thursday, 08'th Jun 2023
I expect Becton, Dickinson and Company to beat 2H23 estimates due to reduced expectations and margin improvements. BDX's management has made progress in SKU rationalizations, workforce reduction, and
BD's (BDX) Latest Product Launch to Boost Research Outcome
12:05pm, Monday, 22'nd May 2023
BD's (BDX) latest cell sorting technology is expected to speed up the process of cell sorting and allow researchers to answer complex biological questions.
BD's (BDX) New FDA Approval to Improve MRSA Diagnostics
01:03pm, Thursday, 18'th May 2023
BD's (BDX) receipt of the latest FDA approval is likely to improve laboratory workflow.
Becton Dickinson CEO: Q2 ‘was another quarter of exceeding expectations'
03:45pm, Thursday, 04'th May 2023
Becton, Dickinson and Company CEO and President Tom Polen joins Yahoo Finance Live to discuss company earnings, growth opportunities in the home test kit market, biotech drugs, strong demand in the we
BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised
12:12pm, Thursday, 04'th May 2023
BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal second quarter.
BD (BDX) Gears Up for Q2 Earnings: What's in the Offing?
03:13pm, Wednesday, 03'rd May 2023
Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited Q2 sales.
Becton, Dickinson and Company: This Serial-Acquirer Is A Buy
09:35am, Saturday, 15'th Apr 2023
The medical devices industry has grown steadily for many decades, driven by people living longer and increased adoption of technologically advanced healthcare devices. Given the predictability of the
BDX vs. WST: Which Stock Is the Better Value Option?
12:55pm, Friday, 14'th Apr 2023
Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Becton Dickinson (BDX) and West Pharmaceutical Services (WST). But which of these two stocks pre
3 Stocks Worth a Buy for Solid Earnings Acceleration
08:24am, Friday, 14'th Apr 2023
Invest in stocks like Becton, Dickinson and Company (BDX), Raytheon Technologies (RTX) & Palantir Technologies (PLTR) as of now for superb earnings acceleration.
Sign In
Buy BDX